Pure Global
NCT05763706

Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy

Evaluating the Efficacy of Photobiomodulation Therapy in the Management of Chemotherapy-induced Peripheral Neuropathy: a Randomized Controlled Trial
Jessa Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chemotherapy-induced Peripheral Neuropathy
Drug/Device/Intervention
Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Jessa Hospital
Location
Hasselt, Belgium
Timeline & enrollment
Phase
N/A
Start date
Mar 27, 2023
End date
Mar 15, 2030
Enrollment
172 participants
Primary outcome

Modified total neuropathy score (mTNS),Modified total neuropathy score (mTNS),Modified total neuropathy score (mTNS),Pain score,Pain score,Pain score,Mobility score,Mobility score,Mobility score

Summary

This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the
 management of chemotherapy-induced peripheral neuropathy (CIPN). Therefore, the hypothesis is
 that PBM can reduce the severity of CIPN in cancer patients, increasing the patient's quality
 of life.

ICD-10 classifications
Drug-induced polyneuropathyParaneoplastic neuromyopathy and neuropathyPolyneuropathy due to other toxic agentsIdiopathic peripheral autonomic neuropathyIdiopathic progressive neuropathy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05763706
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05763706 through Pure Global AI's free database. This phase not specified trial is sponsored by Jessa Hospital and is currently Recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 172 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.